Masco
MAS
$68.87
-1.52%
Masco Corporation is a global manufacturer of branded home improvement and building products, operating primarily in two segments: Plumbing Products (roughly 70% of revenue), which includes faucets, showerheads, and shower systems sold under the Delta, Hansgrohe, and Bristan brands, and Decorative Architectural Products (roughly 30%), which includes Behr paint and other coatings. The company is a market leader in the repair-and-remodel (R&R) channel, with a portfolio of category-leading brands sold through home centers, wholesale distributors, and e-commerce, giving it a distinct competitive identity built on brand equity, scale, and retail shelf space rather than new-construction exposure. The current investor narrative centers on Masco's ability to expand margins and exercise pricing power despite a soft housing and remodeling backdrop, as highlighted by recent headlines noting the stock "shocked the market" with impressive margin expansion; however, this optimism is tempered by a 2.9% year-over-year revenue decline in the most recent quarter and a stock that has underperformed the S&P 500 by more than 18 percentage points over the past year. The debate among investors is whether Masco's margin resilience and aggressive share repurchases can offset weak top-line trends and a challenging R&R demand environment, or whether valuation and growth concerns will keep the stock range-bound.…
MAS
Masco
$68.87
Related headlines
Investment Opinion: Should I buy MAS Today?
We assign a Hold rating on Masco, balancing its strong margin execution and cash generation against stagnant revenue and a challenging demand environment. The analyst consensus is 'buy' with a mean of 2.43 and an average target of $80.33, implying 17.5% upside, but the wide target range ($68-$96) and recent downgrade by Evercore ISI suggest caution. The core thesis is that Masco is a well-managed, cash-generative company with a depressed top line, and the stock is fairly valued until revenue growth returns.
The supporting evidence includes a forward PE of 14.68x, which is below the trailing PE of 16.36x and in the middle of the historical range, suggesting moderate valuation. Revenue declined 2.88% year-over-year in Q2 2026, but gross margin expanded to 43.57% from 37.69%, driving net income up to $318 million from $270 million. Free cash flow is robust at $1.453 billion trailing twelve months, and the company returned $454 million to shareholders in Q2 alone. The dividend yield of 1.97% and payout ratio of 32.2% provide income support, while the interest coverage of 16.79x indicates manageable debt despite negative equity.
The biggest risks are a continued revenue decline, margin reversal, and competitive pressures. The Hold rating would upgrade to Buy if revenue growth turns positive and gross margin holds above 40%, or if the stock drops below $60 (near the 52-week low) offering a better risk/reward. It would downgrade to Sell if revenue declines accelerate beyond 5% year-over-year or if gross margin falls below 35%, signaling a loss of pricing power. Relative to its history and peers, Masco appears fairly valued: the PS ratio of 1.75 is near the low end of its historical range, but the high PEG ratio of 5.61 suggests the market is not paying a premium for growth. Overall, the stock is a solid hold for income and value investors, but lacks a near-term catalyst for significant outperformance.
Sign up to view all
MAS 12-Month Price Forecast
Masco presents a balanced risk/reward profile, with strong margin execution and cash generation offset by stagnant revenue and a challenging demand environment. The stock is fairly valued at 14.68x forward earnings, and the 17.5% upside to the average analyst target is credible if margins hold, but the high PEG ratio and negative revenue trend limit multiple expansion. The neutral stance reflects the tug-of-war between operational efficiency and top-line weakness; we would upgrade to bullish if revenue growth turns positive and gross margin sustains above 43%, or downgrade to bearish if revenue declines accelerate beyond 5% or margins fall below 40%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Masco's 12-month outlook, with a consensus price target around $80.05 and implied upside of +16.2% versus the current price.
Average Target
$80.05
0 analysts
Implied Upside
+16.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$68 - $96
Analyst target range
Masco is covered by 18 analysts, with a consensus recommendation of "buy" and a recommendation mean of 2.43 (on a scale where 1 is Strong Buy and 5 is Strong Sell), indicating a moderately bullish tilt. The average target price is $80.33, which implies approximately 17.5% upside from the current price of $68.36. The consensus is not overwhelmingly bullish, as the recommendation mean of 2.43 falls between Buy and Hold, and recent institutional ratings show a mix of Overweight, Buy, Neutral, and Equal Weight actions, with no recent upgrades or downgrades of significance. The estimated EPS average of $5.47 and estimated revenue average of $8.213 billion suggest that analysts expect modest growth, and the buy rating likely reflects confidence in margin expansion and capital returns rather than robust top-line acceleration.
The target price range spans from a low of $68.00 to a high of $96.00, a wide spread of $28.00, or roughly 41% of the low target, which signals significant disagreement among analysts about the company's prospects. The high target of $96.00 implies a forward PE of about 17.6x on estimated EPS of $5.47, assuming multiple expansion and successful margin initiatives, while the low target of $68.00 is essentially the current price, implying no upside and likely pricing in continued revenue declines and margin compression. The wide spread suggests high uncertainty, which is consistent with the stock's beta of 1.294 and the recent 3-month decline of 17.41%. Institutional ratings show that Wells Fargo maintained Overweight in September 2026, while Evercore ISI downgraded from Outperform to In Line in July 2026, indicating a slight negative shift in sentiment. Given the wide target range and the mixed ratings, the signal strength is moderate, and investors should expect continued volatility as the market awaits clearer evidence of a revenue turnaround.
Bulls vs Bears: MAS Investment Factors
The bull case rests on Masco's impressive margin expansion, strong free cash flow, and attractive forward valuation, supported by a consensus buy rating and 17.5% upside to the average target. The bear case highlights stagnant revenue, severe relative underperformance, and a high PEG ratio that questions the growth premium. Currently, the bear evidence appears slightly stronger because the top-line contraction and negative momentum are concrete and recent, while the margin story, though powerful, may be nearing its peak. The single most important tension is whether Masco can return to revenue growth; if it does, the margin gains could drive significant multiple expansion, but if revenue remains flat or declines, the stock may stay range-bound despite profitability.
Bullish
- Dramatic gross margin expansion: Q2 2026 gross margin reached 43.57%, up from 37.69% in Q2 2025 and 33.69% in Q4 2025, a roughly 590 basis point year-over-year improvement. This reflects strong pricing power and input-cost tailwinds, and it drove operating margin to 23.59% from 20.09% a year earlier.
- Strong free cash flow and capital returns: Trailing twelve-month free cash flow is $1.453 billion, and Q2 2026 alone generated $780 million. The company repurchased $390 million of stock and paid $64 million in dividends in the quarter, funded by $823 million of operating cash flow, demonstrating ample capacity for shareholder returns.
- Analyst consensus sees upside: 18 analysts have a consensus recommendation of 'buy' with a mean of 2.43, and the average target price of $80.33 implies 17.5% upside from the current $68.36. The high target of $96.00 suggests meaningful re-rating potential if margin initiatives continue.
- Attractive forward valuation: The forward PE of 14.68x is below the trailing PE of 16.36x and sits in the middle of the historical range (10.54x to 31.92x). The PS ratio of 1.75 is near the low end of its historical band, suggesting the stock is not expensive relative to its own history.
Bearish
- Revenue contraction and stagnant top line: Q2 2026 revenue declined 2.88% year-over-year to $1.992 billion, and the multi-quarter trend shows revenue oscillating between roughly $1.79 billion and $2.05 billion without a clear growth direction. This limits the multiple the market is willing to pay and undermines the growth narrative.
- Severe relative underperformance: MAS has underperformed the S&P 500 by 18.73 percentage points over the past year and by 20.75 percentage points over the past three months. The 3-month decline of 17.41% is idiosyncratic, not market-driven, signaling company-specific concerns.
- Elevated PEG ratio signals growth mismatch: The PEG ratio of 5.61 is well above 1, indicating that the stock is not cheap relative to its expected earnings growth. With revenue declining, the market may be overpaying for the modest earnings expansion implied by the forward PE.
- Negative book value and high leverage optics: The debt-to-equity ratio of -18.47 and negative P/B of -71.31 reflect negative shareholder equity, a result of aggressive buybacks and impairments. While interest coverage is comfortable at 16.79x, the negative equity makes traditional leverage metrics less meaningful and could deter value-oriented investors.
MAS Technical Analysis
Masco is in a range-bound consolidation phase with a modestly negative longer-term bias, having posted a 1-year price change of -3.72% versus a 15.01% gain for the S&P 500, a relative underperformance of 18.73 percentage points. At the current price of $68.36, the stock sits at approximately 40.1% of its 52-week range of $58.16 to $83.64, meaning it is trading in the lower-middle portion of its annual band, closer to the low than the high. This positioning suggests neither a momentum breakout nor a deep-value falling knife, but rather a market that is undecided on the name, with the 52-week low only about 15% below current levels and the high roughly 22% above. The stock's max drawdown of -24.7% over the period underscores that it has experienced a meaningful correction from its highs, and the current level reflects a market that has repriced the shares lower amid growth concerns.
Short-term momentum is negative and diverging from the longer-term trend: the 1-month change is -3.64% and the 3-month change is -17.41%, both significantly worse than the 1-year change of -3.72%, indicating that the pace of decline has accelerated in recent months. This divergence is notable because the 6-month change is actually positive at +15.63%, meaning the stock rallied strongly into mid-2026 before rolling over sharply in the last three months. The 3-month relative strength versus the S&P 500 is -20.75 percentage points, one of the weakest readings in the dataset, confirming that the recent sell-off is idiosyncratic rather than market-driven. With a short ratio of 4.74, there is a moderate level of short interest that could fuel a squeeze if the stock stabilizes, but the recent price action suggests sellers remain in control.
Key technical levels are defined by the 52-week low of $58.16 as support and the 52-week high of $83.64 as resistance. A breakdown below $58.16 would signal a deeper bearish trend and likely trigger momentum-selling, while a breakout above $83.64 would require a fundamental catalyst to reverse the current downtrend. The stock's beta of 1.294 means it is approximately 29.4% more volatile than the broader market, which is meaningful for position sizing: a 10% market move would imply a roughly 13% move in MAS, and risk management should account for this amplified sensitivity. Given the current price of $68.36, the distance to support is about 15% and to resistance about 22%, offering a roughly 1.5-to-1 reward-to-risk ratio for a range-trading strategy, though the negative 3-month momentum tilts the near-term risk to the downside.
Beta
1.29
1.29x market volatility
Max Drawdown
-24.7%
Largest decline past year
52-Week Range
$58-$84
Price range past year
Annual Return
+0.5%
Cumulative gain past year
| Period | MAS Return | S&P 500 |
|---|---|---|
| 1m | -5.3% | +0.9% |
| 3m | -10.1% | +3.4% |
| 6m | +9.4% | +14.4% |
| 1y | +0.5% | +16.2% |
| ytd | +6.8% | +14.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MAS Fundamental Analysis
Masco's revenue trajectory is showing signs of stagnation and mild contraction: the most recent quarter (Q2 2026) reported revenue of $1.992 billion, a year-over-year decline of 2.88% from $2.051 billion in Q2 2025. Sequentially, revenue rose from $1.918 billion in Q1 2026, but the year-over-year comparison remains negative, and the multi-quarter trend shows revenue oscillating between roughly $1.79 billion and $2.05 billion over the past eight quarters without a clear growth direction. Segment data for the latest quarter shows Plumbing Products at $1.337 billion and Decorative Architectural Products at $655 million, with the plumbing segment (about 67% of the total) remaining the larger but also likely the more cyclical drag given soft R&R demand. The flat-to-declining top line implies that the investment case rests on margin expansion and capital returns rather than organic growth, which limits the multiple the market is willing to pay.
Profitability remains solid despite the revenue softness: Q2 2026 net income was $318 million, up from $270 million in Q2 2025, and the net margin expanded to 15.96% from 13.16% a year earlier. Gross margin in Q2 2026 was 43.57%, a significant improvement from 37.69% in Q2 2025 and 33.69% in Q4 2025, reflecting pricing power and input-cost tailwinds. Operating margin also expanded to 23.59% in Q2 2026 from 20.09% in Q2 2025, and the trailing operating margin of 16.82% and net margin of 10.71% confirm that the company is comfortably profitable. The margin trajectory is clearly positive over the last two quarters, which is the key bullish counterpoint to the weak revenue trend and suggests that management's pricing and productivity initiatives are bearing fruit.
Balance sheet and cash flow metrics present a mixed but generally healthy picture: free cash flow on a trailing twelve-month basis is $1.453 billion, and Q2 2026 alone generated $780 million in free cash flow, a strong conversion of earnings. The current ratio of 1.81 indicates adequate short-term liquidity, and the interest coverage ratio of 16.79x (as of Q2 2026) reflects a comfortable ability to service debt. However, the debt-to-equity ratio of -18.47 and negative book value (reflected in the negative P/B of -71.31) indicate that shareholder equity is negative, a result of aggressive share repurchases and accumulated goodwill impairments, which makes leverage metrics less meaningful. The company returned capital aggressively in Q2 2026, repurchasing $390 million of stock and paying $64 million in dividends, funded by operating cash flow of $823 million, demonstrating that internal cash generation is sufficient to fund both growth capex ($43 million) and shareholder returns without relying on external financing.
Quarterly Revenue
$2.0B
2026-06
Revenue YoY Growth
-2.9%
YoY Comparison
Gross Margin
43.6%
Latest Quarter
Free Cash Flow
$1.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MAS Overvalued?
Because Masco is profitable with positive trailing net income, the PE ratio is the appropriate primary valuation metric. The trailing PE is 16.36x, while the forward PE is 14.68x based on estimated EPS of $5.47, implying that the market expects earnings growth of roughly 11.4% over the next year. The gap between trailing and forward PE is modest but positive, suggesting the market is pricing in moderate earnings expansion rather than a dramatic inflection, which is consistent with a company facing flat revenue but improving margins. The PEG ratio of 5.61, however, is elevated and signals that the stock is not cheap relative to its expected growth rate, a cautionary signal for value-oriented investors.
Compared to the broader Construction Materials sector, Masco's valuation appears mixed: the PS ratio of 1.75 and EV/Sales of 2.19 are relatively low, but the EV/EBITDA of 11.60 and forward PE of 14.68x are not obviously cheap for a company with declining revenue. Without a specific industry average provided in the valuation data, we can note that the net margin of 10.71% and operating margin of 16.82% are healthy for a building products manufacturer, which may justify a modest premium to the sector. However, the negative book value and high PEG ratio suggest that the premium, if any, is not supported by growth, and the stock's 1-year relative underperformance of -18.73 percentage points versus the S&P 500 indicates that the market has already been repricing the shares lower.
Historically, Masco's PE ratio has ranged from a low of 10.54x (Q2 2022) to a high of 31.92x (Q4 2021), with the current trailing PE of 16.36x sitting in the middle of that historical band. The PS ratio of 1.75 is near the low end of its historical range (which has been as high as 9.13x in Q3 2024 and as low as 4.79x in Q3 2022, though those figures appear to reflect different share counts or data conventions), suggesting that on a sales basis the stock is not expensive relative to its own history. The forward PE of 14.68x is below the trailing PE, which historically has been a signal of expected earnings growth, but the high PEG ratio of 5.61 warns that the growth may not be fast enough to justify multiple expansion. Overall, the valuation appears fair-to-slightly-attractive on a PE basis but lacks a clear catalyst for re-rating given the stagnant revenue trend.
PE
16.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~27x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.6x
Enterprise Value Multiple
Investment Risk Disclosure
Masco's financial risks are primarily tied to its stagnant revenue and negative equity. Revenue declined 2.88% year-over-year in Q2 2026 to $1.992 billion, and the top line has oscillated between $1.79 billion and $2.05 billion over eight quarters, showing no clear growth trajectory. The debt-to-equity ratio of -18.47 and negative book value (P/B of -71.31) stem from aggressive share repurchases and impairments, which, while boosting EPS, reduce financial flexibility and make leverage metrics less transparent. Additionally, the company's profitability is heavily reliant on margin expansion, with gross margin jumping to 43.57% in Q2 2026; any reversal in input costs or pricing power could quickly erode earnings, especially given the high PEG ratio of 5.61 that leaves little room for disappointment.
Market and competitive risks are significant given Masco's premium valuation relative to its growth prospects and its sensitivity to the housing cycle. The stock trades at a forward PE of 14.68x, which is not obviously cheap for a company with declining revenue, and the PEG ratio of 5.61 suggests the market may be overvaluing its growth. With a beta of 1.294, Masco is 29.4% more volatile than the market, amplifying downside during sector rotations or macro headwinds. The repair-and-remodel market is highly competitive, and while brands like Delta and Behr are leaders, they face pressure from private-label and lower-cost alternatives, particularly if consumers trade down in a weak economy. Recent news highlights margin expansion, but the 3-month relative underperformance of -20.75 percentage points versus the S&P 500 indicates that investors are concerned about the sustainability of these gains amid soft demand.
The worst-case scenario for Masco would involve a continued decline in repair-and-remodel spending, coupled with margin compression as pricing power fades and input costs rise. If revenue declines accelerate and margins revert toward historical levels (e.g., gross margin back to 35%), earnings could fall well below the estimated EPS of $5.47, leading to multiple compression. In this scenario, the stock could retest its 52-week low of $58.16, representing a 15% decline from the current price of $68.36. A more severe outcome, such as a recession that cuts into home improvement demand, could push the stock toward the analyst low target of $68.00, which is essentially the current price, but if earnings disappoint, the market could price in a lower multiple, potentially driving the stock below $58. The max drawdown of -24.7% over the past year shows that such a decline is plausible, and from the current price, a drop to the 52-week low would equate to a loss of approximately 15%.
FAQ
The most severe risk is revenue stagnation: Q2 2026 revenue fell 2.88% year-over-year, and a continued decline could pressure earnings and the multiple. Second, margin reversal risk: gross margin expanded to 43.57% in Q2 2026, but if input costs rise or pricing power fades, margins could contract, especially given the high PEG ratio of 5.61 that leaves little room for error. Third, competitive and macro risks: with a beta of 1.294, the stock is 29.4% more volatile than the market, and a housing downturn or consumer pullback in R&R spending could disproportionately impact Masco. Fourth, financial structure risk: negative book value and a debt-to-equity ratio of -18.47, while manageable due to strong interest coverage of 16.79x, could limit financial flexibility. Ranked by severity, revenue stagnation and margin reversal are the most immediate threats, followed by macro sensitivity and balance sheet optics.
Our 12-month forecast assigns a 55% probability to the base case, with a target range of $75.00 to $80.33, assuming revenue declines moderate and margins hold, leading to EPS near the consensus of $5.47. The bull case (25% probability) targets $83.64 to $96.00, driven by a revenue turnaround and sustained margin expansion, while the bear case (20% probability) targets $58.16 to $68.00 if revenue declines accelerate and margins compress. The most likely scenario is the base case, where the stock grinds higher toward the analyst average target as investors gain confidence in the margin story and capital returns. The key assumption is that gross margin remains above 42% and free cash flow supports continued buybacks, preventing a breakdown below the 52-week low.
Masco appears fairly valued to slightly undervalued on a PE basis: the trailing PE of 16.36x is in the middle of its historical range (10.54x to 31.92x), and the forward PE of 14.68x is below the trailing multiple, suggesting expected earnings growth. The PS ratio of 1.75 is near the low end of its historical band, indicating the stock is not expensive relative to sales. However, the PEG ratio of 5.61 is elevated, signaling that the market is paying a premium relative to the company's growth rate, which is a concern given declining revenue. Compared to the broader construction materials sector, Masco's net margin of 10.71% and operating margin of 16.82% are healthy, but the negative book value and high PEG ratio suggest the valuation is not a bargain. The market appears to be pricing in modest earnings growth and continued margin expansion, but not a robust revenue recovery.
From a risk/reward perspective, MAS offers a balanced proposition: the average analyst target of $80.33 implies 17.5% upside, and the forward PE of 14.68x is reasonable for a profitable market leader. However, the stock has underperformed the S&P 500 by 18.73 percentage points over the past year, and revenue declined 2.88% year-over-year in Q2 2026, highlighting growth challenges. The biggest downside risk is a retest of the 52-week low of $58.16, about 15% below the current price, if margins compress or revenue declines accelerate. For income-focused investors, the 1.97% dividend yield and strong free cash flow are attractive, but growth investors may want to wait for evidence of a revenue turnaround. Overall, it is a good buy for value and income investors with a medium-term horizon, but not a compelling growth story at this time.
Masco is better suited for long-term investment, given its stable dividend (yield 1.97%), strong free cash flow ($1.453 billion TTM), and market-leading brands that benefit from long-term home improvement trends. The stock's beta of 1.294 and recent 3-month decline of 17.41% indicate above-average volatility, making it less ideal for short-term trading unless one is adept at timing swings. The company's earnings visibility is moderate, with revenue stagnant but margins improving, and the dividend payout ratio of 32.2% suggests room for future increases. A minimum holding period of 2-3 years is recommended to ride out the cyclical R&R demand and allow the margin story to fully materialize. Short-term traders might find opportunities around earnings, but the risk/reward favors a patient, income-oriented approach.